Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients
Clinical trial NCT01944735 · COMPLETED
Trial details
- NCT number
- NCT01944735
- Sponsor
- Celtaxsys, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-10-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.